Business Wire

WORKATO

5.5.2021 01:03:06 CEST | Business Wire | Press release

Share
Workato Commits Further Investment in EMEA After 289% Surge in Usage Over Last 12 Months in the Region

Workato , the leading enterprise automation platform, has today launched its first EMEA data centre in Frankfurt, Germany. The new data centre has been set up in response to exceptionally strong growth in the EMEA region, the company has seen a 289% increase in data usage on its platform from EMEA in the last 12 months. The launch of the data centre is part of the company’s strategy to boost investment twofold in the region and will provide Workato customers with a centralised location for hosting their data and provide assurance that their data residency requirements including GDPR are fully compliant and that their data is secure and protected.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210504006038/en/

The opening of the data centre in Frankfurt is testament to the strong demand Workato is seeing from European enterprises for its integration-led automation.

Workato supports customers throughout EMEA with operations currently in Spain, UK, Germany, France, Ireland, Netherlands and Italy. In January this year, the company announced Series D funding worth $110 million to be used to invest in developing its technology and expanding product innovation to help more companies around the world transform the way they work. Workato’s current customer base comprises of companies from the tech, financial services and fintech, transport and logistics, ecommerce and retail industries and include TFG Transfracht (Deutsche Bahn Group), Box, World Economic Forum (WEF), Showpad, Jumia and WorldRemit. As part of the company’s mission to improve the way enterprises work, Workato forms strategic partnerships with organisations such as Deloitte.

Markus Zirn, SVP of Strategy & Business Development at Workato commented: “The pandemic saw digital transformation catapulted to the top priority for enterprises. With increased focus on digital strategies and remote working, EMEA enterprises quickly recognised the need for automation platforms like Workato to achieve automation at scale by easily, reliably, and securely connecting applications, data, and business processes so teams can work smarter and faster.”

He added:In response to this very strong demand for our technology across EMEA, we have invested in this new data centre, serving our European customers to ensuring their data is held in full compliance with new EU-data regulations, eliminating any risk and allowing us to help more and more businesses within the EU transform the way they work. We are delighted to be investing in this very important region for Workato and to be expanding our operations in EMEA.”

Workato customer, Agatha Sick, Head of IT at TFG Transfracht said: "Workato is enabling us to automate workflows across our enterprise.” She continued, “We are excited about the launch of the data centre in Europe as this will provide us with the option to store our data in the EU and comply with the EU data protection regulations."

Mark Watson, Chief Technology Officer at WorldRemit , another Workato customer added: “Workato’s powerful low-code/no-code integration and automation platform is enabling us to achieve automation at scale. We are excited about the launch of Workato’s Data Center in the European Union as it will enable us to keep our data close to home.”

Workato allows companies to maximise the value of their apps, data and people by making it easy to integrate disconnected data and applications, and securely automate workflows to accelerate business outcomes. Workato’s no code/low code platform combines enterprise-grade integration and automation capabilities in a single platform that is trusted by IT and easy to use for the business. With Workato, IT and business teams can more easily collaborate to rapidly integrate data, processes, applications and user experiences in almost any combination without compromising security and governance.

About Workato

Workato is the leading Enterprise Automation Platform. Recognised as a leader, Workato is the only enterprise platform that enables both business and IT to integrate their apps, automate business workflows, and drive real time outcomes from business events, without compromising security and governance. Workato is trusted by over 7,000 of the world’s top brands and fastest growing innovators.

Link:

ClickThru

Social Media:

https://www.facebook.com/workato

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 07:00:00 CEST | Press release

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the

Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 04:00:00 CEST | Press release

Milestone-based government program supports multiple fusion approaches toward power demonstration and commercialization Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated ove

Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]31.8.2026 23:35:00 CEST | Press release

ITC Infotech Board approves proposed acquisition of 22.1% promoter stake and a Scheme of Amalgamation of the two companies ITC Infotech (ITCI), a wholly owned subsidiary of ITC Limited and a leading global technology services player, today announced the proposed strategic combination with Happiest Minds Technologies Limited (Happiest Minds) to create a scaled, future-ready, AI-first global technology services enterprise. The ITCI Board approved a proposal to acquire 22.1% equity stake from the promoter of Happiest Minds in two tranches under a Share Purchase Agreement. The transaction would be funded through a Rights Issue by ITC Infotech. ITCI Board has also approved a proposed Scheme of Amalgamation of Happiest Minds with ITCI which will be effected after the share acquisition. Pursuant to the scheme, the shares of ITCI will be listed on the stock exchanges. The proposed transaction has also been endorsed by the Board of Directors of ITC Limited. This strategic combination will syner

Angel’s Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule31.8.2026 21:07:00 CEST | Press release

Angelalign Technology Inc. (“Angel” or the “Company”) (6699.HK) (angelaligner.com), the second largest clear aligner supplier by revenue, announced today that its revenue grew 42.9% to US$230.7 million and net profit grew 79.6% to $25.5 million for the six months ending June 30, 2026. Angel’s business in Europe and North America crossed into profitability ahead of plan while the business in Chinese mainland delivered market share gains well above expectations. Doctors and staff in every region report that they are increasingly selecting Angel’s solutions after experiencing more predictable outcomes, especially on complex cases, and embracing the positive culture of the company. Dr. Mark Holt D.D.S., M.S. of Holt Orthodontics in Northern California, states: “We treat over half of our patients with clear aligners and our experience with Angel’s treatment plans and clear aligners has been tremendous.” “Our main focus is to provide great service to and being a rock-solid partner for our cu

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines31.8.2026 21:00:00 CEST | Press release

Agreement advances patient access and strengthens BeOne's long-term commitment to U.S. innovation and manufacturing BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as we expand our U.S. investment in additional res

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye